首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study
【24h】

High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study

机译:高成纤维细胞生长因子23与高脂联素患者的冠状动脉钙化有关:历史慢性肾病患者的历史思想研究(知识CKD)研究的分析

获取原文
获取原文并翻译 | 示例
       

摘要

Background. The association between fibroblast growth factor 23 (FGF23) and coronary artery calcification (CAC) was inconclusive. Recently it was shown that adiponectin modulates renal handling of calcium and phosphorus. We hypothesized that adiponectin plays a role in the effect of FGF23 on CAC and explored whether the association between FGF23 and CAC is modified by serum adiponectin level in chronic kidney disease (CKD) patients.
机译:背景。 成纤维细胞生长因子23(FGF23)和冠状动脉钙化(CAC)之间的关联不确定。 最近表明脂联素调节钙和磷的肾脏处理。 我们假设脂联素在FGF23对CAC的影响中发挥作用,并探讨了FGF23和CAC之间的关联是否通过慢性肾病(CKD)患者的血清脂联素水平来修改。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号